Published in Blood Weekly, August 7th, 1995
The initial withdrawal was announced on July 12, 1995, the day after the medical director of the Red Cross Vancouver Center received information that a blood donor had been diagnosed with probable CJD. The second precautionary withdrawal was initiated on July 18, 1995, when the Red Cross learned that a donor from Toronto also was diagnosed with probable CJD.
The Canadian Red Cross is withdrawing all plasma derivative products made...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (1995-08-07)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.